Skip to content
UpLiftRx
MedicationsLabsProvidersVisitsOrdersDashboardSign in
UpLiftRx
MedicationsLabsProvidersVisitsOrdersDashboard
Sign in
Transparency
  • Company
  • Our clinicians
  • Pharmacy partners
  • Where we operate
  • Accreditation
Legal
  • Terms of Service
  • Privacy Policy
  • Notice of Privacy Practices
  • Telehealth Consent
  • Auto-Renewal Terms
  • Refund & Shipping
  • Pharmacy Disclosure
  • Prescribing Policy
  • Patient Rights & Nondiscrimination
  • Texas Medical Board Complaint Notice
  • SMS Terms
  • Cookies
  • California Privacy
  • Accessibility
Support
  • support@upliftrx.co
  • Member sign in

Medical emergency? Call 911. In crisis? Call or text 988 (Suicide & Crisis Lifeline). UpLiftRX is not for emergencies.

Prescription products require an online consultation with an independent, licensed clinician, who decides whether treatment is appropriate. Available to adults 18+ in states where our clinicians are licensed.

Compounded medications are prepared by state-licensed pharmacies for an individual patient and are not FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed.

Latitude Investments Management Ltd. Liability Co. d/b/a UpLiftRX provides a technology platform and is not a pharmacy or a medical provider. Medical services are provided by independent, licensed clinicians of a professional medical group (being finalized). Prescriptions are dispensed by independent, state-licensed pharmacies. Latitude Investments Management Ltd. Liability Co., a Wyoming limited liability company (filing no. 2024-001499647), 5709 Gardendale Dr, STE D, Houston, TX 77092.

Wegovy® and Saxenda® are registered trademarks of Novo Nordisk A/S. Zepbound® and Cialis® are registered trademarks of Eli Lilly and Company. Contrave® is a registered trademark of Currax Pharmaceuticals LLC. Viagra® is a registered trademark of Viatris Specialty LLC. All trademarks are the property of their respective owners. UpLiftRX is not affiliated with or endorsed by any drug manufacturer, and generic medications are not the brand-name products.

© 2026 Latitude Investments Management Ltd. Liability Co. d/b/a UpLiftRX.
  1. Home/
  2. Medications/
  3. Wellness/
  4. Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride
Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride topical, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness

Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride Topical

Topical

Condtioner - Fluocinonide / Minoxidil / Tretinoin / Finasteride 60 mL, 0.0125 mg/6.25 mg/0.0125 mg/0.025 mg/gm. The prescriber sets the dose.

$110/ month· visit, medication & shipping · charged only if prescribed
Specification
Just this one: start consultation

Add several treatments and check out once. $0 today; each is charged only if prescribed.

Rx only · adults 18+. Requires an online consultation with an independent, licensed clinician, who decides whether treatment is appropriate. Compounded medications are prepared by a state-licensed pharmacy and are not FDA-approved.

Safety: Finasteride and dutasteride can cause birth defects in a male fetus. Important safety information

Know before you start

How Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride treatment works

How it works

Wellness and sleep protocols pair targeted prescriptions and micronutrient injectables — like NAD+, methylated B-complex, glutathione, and circadian-supporting compounds — to address the biochemical side of energy, recovery, and sleep quality.

What to expect

  • Your clinician matches the protocol to your goal and screens for interactions.
  • Effects build over weeks; injectables are typically dosed 1–3× weekly.
  • Adjustments at monthly check-ins based on your response.

Common side effects

  • Injection-site soreness
  • Flushing or nausea if dosed too quickly (NAD+)
  • Vivid dreams or grogginess while titrating sleep support

Safety & who it's not for

Tell your clinician about all medications and supplements you take. Wellness compounds are compounded preparations and are not FDA-approved as finished products.

Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride FAQ

What is Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride?

Condtioner - Fluocinonide / Minoxidil / Tretinoin / Finasteride 60 mL, 0.0125 mg/6.25 mg/0.0125 mg/0.025 mg/gm. The prescriber sets the dose. It is compounded for you by a state-licensed 503A pharmacy and is not FDA-approved.

How much does Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride cost?

Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride starts at $110 per month through UpLiftRX. The price includes the online clinician visit, the medication, and shipping. Your card is charged only if a licensed clinician prescribes it.

How is Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride taken?

Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride is taken applied to the skin. Typical pharmacy directions read: "Apply 1 g (13 mcg/6.25 mg/13 mcg/25 mcg/gm) to the scalp once daily." Your clinician sets your actual dose and schedule, and the pharmacy label on your prescription is what you follow.

Is Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride FDA-approved?

No. Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride is a compounded preparation, and compounded drugs are not FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed.

Do I need a prescription for Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride?

Yes. Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride requires a prescription. Start an online visit, answer the health questionnaire, and a licensed clinician reviews it. If Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride is appropriate, the clinician prescribes it and a licensed pharmacy ships it to you.

How should I store Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride?

Store at room temperature, away from heat and moisture.

Where does Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride ship?

Pharmacies in our network can ship Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride to 42 states (not California). It is not currently available in 9 states; the online visit checks your state first. Orders typically arrive in 2 days after the pharmacy ships, and shipping is included in the price.

What does the research say about Minoxidil?

PubMed indexes 3,046 publications that mention Minoxidil, including 271 randomized trials, systematic reviews, or meta-analyses. ClinicalTrials.gov lists 111 registered studies. Study results for FDA-approved products do not transfer automatically to compounded preparations. The sources are linked on this page.

Is this a substitute for sleep hygiene?

No — it's a complement. Your care plan includes the behavioral foundations; the protocol addresses the biochemical side.

How fast will I feel it?

Some members feel a difference within days (B-complex, NAD+); circadian and recovery changes typically take 2–4 weeks of consistency.

Important safety information

Boxed warning: Risk to a male fetus and contact precautions

Finasteride and dutasteride can cause birth defects in a male fetus. Women who are pregnant or could become pregnant must not handle crushed or broken tablets or take this medication. Some men report mood changes or sexual side effects on these medications — tell your clinician if you have a history of depression or sexual dysfunction.

Photosensitivity and pregnancy

Tretinoin makes your skin sensitive to sunlight. Daily broad-spectrum SPF 30+ is required while you use it. Do not use during pregnancy or while trying to conceive — discuss timing with your clinician.

Compounded drugs are not FDA-approved; FDA does not review them for safety, effectiveness, or quality before they are dispensed. Tell your clinician about all medications and supplements you take. Seek emergency care (call 911) for severe reactions. Report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Similar products

Similar to Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride

See all in Wellness →
Conditioner - Fluocinonide + Minoxidil + Tretinoin topical, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Conditioner - Fluocinonide + Minoxidil + Tretinoin
0.0125 mg/6.25 mg/0.0125 mg/gm
Metformin ER oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Metformin ER
2 options
Sertraline HCl oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Sertraline HCl
2 options
Bupropion oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Bupropion
150 mg SR
Fluoxetine oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Fluoxetine
20 mg
Ivermectin oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Ivermectin
4 options
Ondansetron Oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Ondansetron Oral
4 mg
Ciprofloxacin oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Wellness
Ciprofloxacin
500 mg
$110/mo
On this pageOverviewStrengths & pricesHow it's takenStorage & shippingResearch & sourcesFAQReviewsSafety
At a glance

What is Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride Topical?

Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride is a compounded topical preparation prepared for an individual patient by a state-licensed 503A compounding pharmacy. It is not FDA-approved. Route: applied to the skin. Through UpLiftRX it costs from $110 per month, including the online visit, the medication, and shipping. You are charged only if a licensed clinician prescribes it. It can ship to 42 states (not California).

Form
Topical
Route
Applied to the skin
Active ingredients
Conditioner - Fluocinonide, Minoxidil, Tretinoin, Finasteride
Options
1 strength and size option
Price
$110 per month, visit and shipping included
Prescription
Required. A licensed clinician decides whether it is appropriate.
FDA status
Compounded. Not FDA-approved; FDA does not review compounded drugs before they are dispensed.
Dispensed by
A state-licensed 503A compounding pharmacy
Ships to
42 states (not California)
Storage
Store at room temperature, away from heat and moisture.
Availability
In stock at one or more pharmacies

Product details from our pharmacy network's catalog, updated October 22, 2026.

Strengths & prices

Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride Topical strengths and prices

1 option. Prices are per month and include the online visit, the medication, and shipping; you are charged only if a clinician prescribes it.
StrengthSizePriceAvailability
0.0125 mg/6.25 mg/0.0125 mg/0.025 mg/gm1 each cream (12.5 mcg total)$110In stock
How it's taken

How to take Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride Topical

Route and directions

Route: Applied to the skin

Example pharmacy label: “Apply 1 g (13 mcg/6.25 mg/13 mcg/25 mcg/gm) to the scalp once daily.”

Your clinician sets your dose and schedule. Follow the label on your own prescription, not this example.

Preparation and supplies

Mixing: None. It ships ready to use.

Storage & shipping

Storing and shipping Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride Topical

Storage

Store at room temperature, away from heat and moisture.

Keep out of reach of children. Do not use after the beyond-use date on the label.

Shipping

Ships to 42 states (not California), typically arriving in 2 days after the pharmacy ships. Shipping is included in the price.

States it ships to

Alaska, Arizona, Colorado, Connecticut, Delaware, Florida, Georgia, Iowa, Idaho, Illinois, Indiana, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Missouri, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia, Wyoming

Clinical research & sources

Research on the ingredients in Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride Topical

Published research and public drug references for each active ingredient, from the U.S. National Library of Medicine (PubMed, MedlinePlus, DailyMed, RxNorm, PubChem), ClinicalTrials.gov, and FDA. These studies are about the ingredients, often in FDA-approved products. None of them tested this compounded preparation, and their results do not automatically apply to it.

Conditioner - Fluocinonide

FDA status: We found no FDA-approved drug product listing conditioner - fluocinonide as an active ingredient in openFDA.

Minoxidil

FDA status: FDA has approved products that contain minoxidil, including Arthcal Estrogen, Basic Care Hair Regrowth Treatment, Carols Daughter Hair Regrowth Treatment.

PubMed: 3,046 publications mention Minoxidil, 271 of them trials or reviews. Search PubMed

  1. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. Penha MA et al. JAMA dermatology, 2024. Randomized Controlled Trial. PMID 38598226 · DOI
  2. Management of androgenic alopecia: a systematic review of the literature. Rosenthal A et al. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2024. Systematic Review. PMID 38852607 · DOI
  3. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. Adil A et al. Journal of the American Academy of Dermatology, 2017. Meta-Analysis, Systematic Review. PMID 28396101 · DOI
  4. Treatment of pediatric alopecia areata: A systematic review. Barton VR et al. Journal of the American Academy of Dermatology, 2022. Systematic Review. PMID 33940103 · DOI
  5. Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis. Ahmed KMA et al. Archives of dermatological research, 2025. Systematic Review, Meta-Analysis. PMID 40056230 · DOI

ClinicalTrials.gov: 111 registered studies. See all studies

  • NCT07862374 Oral Minoxidil With or Without a Multifactorial Drinkable Nutraceutical in Female Pattern Hair Loss: a Retrospective Study, not yet recruiting

MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 6984 ↗PubChem CID 4201 ↗Wikipedia ↗

Tretinoin

FDA status: FDA has approved products that contain tretinoin, including Renova, Retin-A, Tri-Luma, Twyneo.

ClinicalTrials.gov: 406 registered studies. See all studies

  • NCT00647556 Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage (Phase 3), completed

MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 10753 ↗PubChem CID 444795 ↗Wikipedia ↗

Finasteride

FDA status: FDA has approved products that contain finasteride, including Propecia, Proscar.

PubMed: 3,561 publications mention Finasteride, 445 of them trials or reviews. Search PubMed

  1. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. Piraccini BM et al. Journal of the European Academy of Dermatology and Venereology : JEADV, 2022. Randomized Controlled Trial. PMID 34634163 · DOI
  2. Management of androgenic alopecia: a systematic review of the literature. Rosenthal A et al. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2024. Systematic Review. PMID 38852607 · DOI
  3. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. Adil A et al. Journal of the American Academy of Dermatology, 2017. Meta-Analysis, Systematic Review. PMID 28396101 · DOI
  4. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Lee S et al. Acta dermato-venereologica, 2019. Meta-Analysis, Systematic Review.

Sources checked October 22, 2026. Listing a study is not a claim that this product is safe or effective for you; a licensed clinician makes that decision.

Patient reviews

Reviews come only from patients who received Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride Topical through UpLiftRX. Each is checked for privacy and safety before it's published; we never remove a review for being negative. Individual experiences vary, and reviews aren't medical advice.

No reviews yet. Patients who receive Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride Topical through UpLiftRX can leave a review after delivery.

For patients who received Conditioner - Fluocinonide + Minoxidil + Tretinoin + Finasteride Topical.
PMID 30206635
· DOI
  • Androgenetic alopecia: a review. Lolli F et al. Endocrine, 2017. Systematic Review. PMID 28349362 · DOI
  • ClinicalTrials.gov: 95 registered studies. See all studies

    • NCT02213107 Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer. (Phase 2), completed
    • NCT00564252 Topical Finasteride in the Treatment of Idiopathic Hirsutism, completed

    MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 25025 ↗PubChem CID 57363 ↗Wikipedia ↗